Outset Medical (OM) Cash & Current Investments (2019 - 2026)
Outset Medical (OM) posted quarterly Cash & Current Investments of $286.6 million for Q1 2026, down 6.13% year-over-year from $305.4 million in Q1 2025, and up 69.67% quarter-over-quarter from $168.9 million in Q4 2025.
Outset Medical (OM) Cash & Current Investments (2019 - 2026) Analysis & Trends
Outset Medical (OM) has reported Cash & Current Investments for 8 consecutive years, with $286.6 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Cash & Current Investments fell 6.13% year-over-year to $286.6 million; the TTM figure through Mar 2026 stood at $286.6 million (down 6.13% YoY), while the FY2025 annual figure was $168.9 million, up 6.47% from the prior year.
- Cash & Current Investments advanced to $286.6 million in Q1 2026 per OM's latest filing, from $168.9 million in the prior quarter.
- Across five years, Cash & Current Investments topped out at $305.4 million in Q1 2025 and bottomed at $158.7 million in Q4 2024.
- Historically, Cash & Current Investments has averaged $226.0 million across 5 years, with a median of $222.8 million in 2023.
- Annual changes were most pronounced in 2022 — Cash & Current Investments slumped 39.01% — and 2025, when it surged 32.63%.
- Outset Medical's Cash & Current Investments stood at $290.8 million in 2022, then declined by 28.94% to $206.7 million in 2023, then decreased by 23.21% to $158.7 million in 2024, then advanced by 6.47% to $168.9 million in 2025, then soared by 69.67% to $286.6 million in 2026.
- Business Quant data shows OM's Cash & Current Investments at $286.6 million in Q1 2026, $168.9 million in Q4 2025, and $178.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 5.60 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 3.48 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 9.22 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 539.00 Mn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 4.25 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 1.95 Bn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 2.11 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 3.32 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 482.30 Mn |
| 10 | Outset Medical | 80.25 Mn | -182.94 Mn | 13.28 Mn | 263.19 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 263.19 Mn |
| Mar 31, 2026 | 286.64 Mn |
| Dec 31, 2025 | 168.95 Mn |
| Sep 30, 2025 | 178.64 Mn |
| Jun 30, 2025 | 184.09 Mn |
| Mar 31, 2025 | 305.37 Mn |
| Dec 31, 2024 | 158.69 Mn |
| Sep 30, 2024 | 178.96 Mn |
| Jun 30, 2024 | 194.85 Mn |
| Mar 31, 2024 | 230.25 Mn |
| Dec 31, 2023 | 206.65 Mn |
| Sep 30, 2023 | 194.00 Mn |
| Jun 30, 2023 | 222.79 Mn |
| Mar 31, 2023 | 249.21 Mn |
| Dec 31, 2022 | 290.81 Mn |
| Sep 30, 2022 | 227.52 Mn |
| Jun 30, 2022 | 262.06 Mn |
| Mar 31, 2022 | 302.27 Mn |
| Dec 31, 2021 | 372.80 Mn |
| Sep 30, 2021 | 373.04 Mn |